secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0000950170-23-007304
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Howson to retire from Cue Biopharma board at 2023 annual meeting
-------------------------------------------------------------------------

- Ms. Howson informed the board on March 7, 2023 of her retirement.
- She will not stand for re-election at the 2023 annual meeting.
- Retirement is not due to any disagreement with company operations.
- Howson currently serves on Compensation and Governance committees.
- No replacement director has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000095017023007304/0000950170-23-007304-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000095017023007304/cue-20230307.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-007304

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer